Melbourne, May 6, 2009 (ABN Newswire) - Leading developer of RNA interference (RNAi)-based therapeutics Benitec Limited (ASX:BLT)(PINK:BNIKF) announced today that Dr John Zaia had presented an update on City of Hope’s HIV human stem cell study at an international conference in San Diego, USA.
